Iridian Asset Management’s Nuvectis Pharma NVCT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$2.78M	Buy	372,717 +118,745	+47%	+$887K	0.96%	29
2025 Q1	$2.48M	Buy	+253,972	New	+$2.48M	0.78%	31
2024 Q4	–	Sell	-55,380	Closed	-$348K	–	53
2024 Q3	$348K	Buy	+55,380	New	+$348K	0.07%	48